Samples and sequencing
Total ten subjects were included in this study. They were enrolled from the Seoul National University Hospital and Seoul National University Bundang Hospital in Korea. They were all diagnosed with breast cancer, with a history of two or more affected family members and/or other risk factors, like bilateral breast cancer or young age of onset. Exome capture was carried out with the blood samples of the ten subjects using Agilent exome capture kits (SureSelect V2) and sequencing was performed on the (Illumina, San Diego, CA, USA).